| PERIOD ENDING | 25-Sep-09 | 26-Jun-09 | 27-Mar-09 | 26-Dec-08 | | Total Revenue | 74,797 | 82,421 | 78,895 | 89,642 | | Cost of Revenue | 56,784 | 63,097 | 59,686 | 70,597 | | | Gross Profit | 18,013 | 19,324 | 19,209 | 19,045 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,657 | 24,378 | 28,816 | 29,323 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,644) | (5,054) | (9,607) | (10,278) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 211 | 228 | 4,476 | 1,225 | | Earnings Before Interest And Taxes | (6,433) | (4,826) | (5,131) | (9,053) | | Interest Expense | 4,054 | 4,964 | 3,625 | 3,896 | | Income Before Tax | (10,487) | (9,790) | (8,756) | (12,949) | | Income Tax Expense | (91) | 188 | (192) | (58) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,396) | (9,978) | (8,564) | (12,891) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (10,396) | (9,978) | (8,564) | (12,891) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,396) | ($9,978) | ($8,564) | ($12,891) |
|
0.20% Nasdaq 
0.15%
Income Statement
